Stephen Liu: The seminal PROFILE 1001 trial of crizotinib in ALK and ROS1 NSCLC

Stephen Liu shared on X:

“Watch for a special episode of the IASLC podcast, Lung Cancer Considered where Dr. Narjust Florez and I review the seminal PROFILE 1001 trial of crizotinib in ALK and ROS1 NSCLC with the incomparable Drs. Alice Shaw, Ben Solomon and Sai-Hong Ignatius Ou. Coming next week! ”

Source: Stephen Liu/X

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.